Autonomic drugs in ophthalmology: some problems and promises. Section III: Sympathomimetic drugs.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000420:Albuterol / Q000494:pharmacology; D000818:Animals; D001082:Aqueous Humor / Q000187:drug effects; D002415:Cats; D003315:Cornea / Q000187:drug effects; D003864:Depression, Chemical; D004837:Epinephrine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D005128:Eye Diseases / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D005901:Glaucoma / Q000188:drug therapy / Q000503:physiopathology; D000882:Haplorhini; D006801:Humans; D006940:Hyperemia / Q000503:physiopathology; D007429:Intraocular Pressure / Q000187:drug effects; D007498:Iris / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology; D007908:Lens, Crystalline / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010656:Phenylephrine / Q000009:adverse effects / Q000494:pharmacology; D011817:Rabbits; D011941:Receptors, Adrenergic / Q000187:drug effects; D012164:Retinal Diseases / Q000139:chemically induced; D013268:Stimulation, Chemical; D013562:Sympathectomy; D013566:Sympathomimetics
D000318:Adrenergic beta-Agonists; D011941:Receptors, Adrenergic; D013566:Sympathomimetics; D010656:Phenylephrine; D007545:Isoproterenol; D000420:Albuterol; D009638:Norepinephrine; D004837:Epinephrine